2-Arachidonoyl Glycerol (2-AG) Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 487 studies associated with 2-Arachidonoyl Glycerol (2-AG).
Here is a small sampling of 2-Arachidonoyl Glycerol (2-AG) studies by title:
- Nutrient composition of different energy-restricted diets determines plasma endocannabinoid profiles and adipose tissue DAGL-α expression; a 12-week randomized controlled trial in subjects with abdominal obesity
- Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex
- Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
- Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior
- Circulating Endocannabinoid Levels as Potential Biomarkers for Mortality in Hemodialysis Patients
Components of the 2-Arachidonoyl Glycerol (2-AG) Research Dashboard
- Top medical conditions associated with 2-Arachidonoyl Glycerol (2-AG)
- Proven effects in clinical trials for 2-Arachidonoyl Glycerol (2-AG)
- Receptors associated with 2-Arachidonoyl Glycerol (2-AG)
- Individual study details for 2-Arachidonoyl Glycerol (2-AG)
Ready to become a subscriber? Go to our PRICING page.
Page Quick Links
Select New Cannabinoid
Overview - 2-Arachidonoyl Glycerol (2-AG)
Description of 2-Arachidonoyl Glycerol (2-AG)
Raphaeal Mechoulam's et al., from the Hebrew University, Israel and T. Sugiura et al., from Teikyo University, Japan described the discovery of a second endogenous cannabinoid subsequently named 2-arachidonoylglycerol (2-AG) in 1994-1995.
2-AG is an ester formed from the essential fatty acid omega-6-arachidonic acid and glycerol.
Monoacylglycerol lipase (MAGL) is a key enzyme that metabolizes 2-AG.
Other Names:
2-Arachidonoyl Glycerol2-Arachidonylglycerol, 2-arachidonoylglycerol, 2-Arachidonoyl Glycerol (and numerous others)
IUPAC Name: 1,3-dihydroxypropan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
Molecular Formula: C23H38O4
Source–PubChem
2-Arachidonoyl Glycerol (2-AG) Properties and Effects
Only Members can view Properties and Effects information. See DEMO page.
2-Arachidonoyl Glycerol (2-AG) Receptor Binding
Only Members can view Receptor Binding information. See DEMO page.
Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You
should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a
medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
